SPOTLIGHT -
Ocular Therapeutix to present 12-month top-line data from Phase 1 OTX-TKI trial for wet AMD at the 2023 Clinical Trials at the Summit Annual Meeting
Ocular Therapeutix is scheduled to present trial results as well as participate in a panel discussion and sponsor a presentation at the 2023 Clinical Trials at the Summit Annual Meeting.
